Monitoring EGFR-Mutant Lung Cancers By Means of the Blood

Hideharu Kimura, Kazuo Kasahara, Kazuhiko Shibata, Takashi Sone, Akihiro Yoshimoto, Toshiyuki Kita, Yukari Ichikawa, Yuko Waseda, Kazuyoshi Watanabe, Hiroki Shiarasaki, Yoshihisa Ishiura, Masayuki Mizuguchi, Yasuto Nakatsumi, Tatsuhiko Kashii, Masashi Kobayashi, Hideo Kunitoh, Tomohide Tamura, Kazuto Nishio, Masaki Fujimura, Shinji Nakao, EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 1, pp. 260- 267 ,(2006) , 10.1016/S1556-0864(15)31577-X

Qiulu Pan, William Pao, Marc Ladanyi, Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas The Journal of Molecular Diagnostics. ,vol. 7, pp. 396- 403 ,(2005) , 10.1016/S1525-1578(10)60569-7

William Pao, Vincent A. Miller, Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non–Small-Cell Lung Cancer: Current Knowledge and Future Directions Journal of Clinical Oncology. ,vol. 23, pp. 2556- 2568 ,(2005) , 10.1200/JCO.2005.07.799

William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073

Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos, EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib The New England Journal of Medicine. ,vol. 352, pp. 786- 792 ,(2005) , 10.1056/NEJMOA044238

Heidi Greulich, Tzu-Hsiu Chen, Whei Feng, Pasi A Jänne, James V Alvarez, Mauro Zappaterra, Sara E Bulmer, David A Frank, William C Hahn, William R Sellers, Matthew Meyerson, Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants PLoS Medicine. ,vol. 2, pp. e313- ,(2005) , 10.1371/JOURNAL.PMED.0020313

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938

MS Kopreski, FA Benko, C Kwee, KE Leitzel, E Eskander, A Lipton, CD Gocke, Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. British Journal of Cancer. ,vol. 76, pp. 1293- 1299 ,(1997) , 10.1038/BJC.1997.551

TATSUO KIMURA, WILL S. HOLLAND, TOMOYA KAWAGUCHI, STEPHEN K. WILLIAMSON, KARI CHANSKY, JOHN J. CROWLEY, JAMES H. DOROSHOW, HEINZ-JOSEF LENZ, DAVID R. GANDARA, PAUL H. GUMERLOCK, Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy. Annals of the New York Academy of Sciences. ,vol. 1022, pp. 55- 60 ,(2004) , 10.1196/ANNALS.1318.010

W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, H. Varmus, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 13306- 13311 ,(2004) , 10.1073/PNAS.0405220101